These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38408033)

  • 1. Compromise in Docking Power of Liganded Crystal Structures of M
    Zajaček D; Dunárová A; Bucinsky L; Štekláč M
    J Chem Inf Model; 2024 Mar; 64(5):1628-1643. PubMed ID: 38408033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro.
    Zev S; Raz K; Schwartz R; Tarabeh R; Gupta PK; Major DT
    J Chem Inf Model; 2021 Jun; 61(6):2957-2966. PubMed ID: 34047191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pea eggplant (
    Govender N; Zulkifli NS; Badrul Hisham NF; Ab Ghani NS; Mohamed-Hussein ZA
    PeerJ; 2022; 10():e14168. PubMed ID: 36518265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids.
    Thangavel N; Albratty M
    J King Saud Univ Sci; 2023 Jan; 35(1):102402. PubMed ID: 36338939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
    Sarfaraz S; Muneer I; Liu H
    J Comput Aided Mol Des; 2020 Dec; 34(12):1237-1259. PubMed ID: 33034007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance of Several Docking Programs at Reproducing Protein-Macrolide-Like Crystal Structures.
    Castro-Alvarez A; Costa AM; Vilarrasa J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28106755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the substrate-binding site of main protease for the structure-based COVID-19 drug discovery.
    Firouzi R; Ashouri M; Karimi-Jafari MH
    Proteins; 2022 May; 90(5):1090-1101. PubMed ID: 35119780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Covalent Docking Tools.
    Scarpino A; Ferenczy GG; Keserű GM
    J Chem Inf Model; 2018 Jul; 58(7):1441-1458. PubMed ID: 29890081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.
    Wang Z; Sun H; Yao X; Li D; Xu L; Li Y; Tian S; Hou T
    Phys Chem Chem Phys; 2016 May; 18(18):12964-75. PubMed ID: 27108770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 M
    Soulère L; Barbier T; Queneau Y
    Comput Biol Chem; 2021 Jun; 92():107463. PubMed ID: 33677227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL
    Saquib Q; Bakheit AH; Ahmed S; Ansari SM; Al-Salem AM; Al-Khedhairy AA
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Assessment of Pose Prediction Accuracy in RNA-Ligand Docking.
    Agarwal R; T RR; Smith JC
    J Chem Inf Model; 2023 Dec; 63(23):7444-7452. PubMed ID: 37972310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
    Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
    Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function.
    Wang Z; Zheng L; Wang S; Lin M; Wang Z; Kong AW; Mu Y; Wei Y; Li W
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36502369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies.
    Halimi M; Bararpour P
    J Mol Model; 2022 Aug; 28(9):279. PubMed ID: 36031629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
    Rehman MT; AlAjmi MF; Hussain A
    Curr Pharm Des; 2021; 27(33):3577-3589. PubMed ID: 33200697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dockECR: Open consensus docking and ranking protocol for virtual screening of small molecules.
    Ochoa R; Palacio-Rodriguez K; Clemente CM; Adler NS
    J Mol Graph Model; 2021 Dec; 109():108023. PubMed ID: 34555725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M
    Bassani D; Pavan M; Bolcato G; Sturlese M; Moro S
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
    Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.